TLSA logo
TLSA NASDAQ GB

Tiziana Life Sciences Ltd - Common Shares

Healthcare · Biotechnology Website · IPO Nov 2018
$1.25
▲ +$0.00 (+0.00%)
Vol 111K
4
Quality Score
fail
Mkt Cap
$177.1M
ROE
-195.5%
D/E
1.16
Beta
-0.11
52W
$1–$3

Wall Street Consensus

7 analysts · Apr 2026
2
Strong Buy
4
Buy
1
Hold
0
Sell
0
Strong Sell
85.7%
Buy Rating

Price Chart

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -195.5% -409.7% -409.7% -195.5% -195.5% -195.5%
P/E (TTM)
Net Margin
Gross Margin
D/E Ratio 1.16 2.69 2.69 1.16 1.16 1.16
Current Ratio 1.72 1.02 1.02 1.72 1.72 1.72

Key Ratios

ROA (TTM)
-92.1%
P/B
19.6
EPS (TTM)
$-0.11
CF/Share
$-0.15
52W High
$2.60
52W Low
$0.63
$0.63 52-Week Range $2.60

How does TLSA compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

TLSA AAPG ABEO ABOS ABP

TLSA valuation vs Biotechnology peers

P/E ratio
0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
0% below peers (12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
19.6
696% above peers (2.5)
vs Peers
vs Industry
Overvalued
Div yield
0% below peers (0.0%)
vs Peers
vs Industry
Low yield

TLSA profitability vs Biotechnology peers

ROE
-195.5%
191% below peers (-67.3%)
vs Peers
vs Industry
Weak
Net margin
0% below peers (-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
0% below peers (78.6%)
vs Peers
vs Industry
In line
ROA
-92.1%
97% below peers (-46.7%)
vs Peers
vs Industry
Weak

TLSA financial health vs Biotechnology peers

D/E ratio
1.2
0% below peers (0.0)
vs Peers
vs Industry
In line
Current ratio
1.7
61% below peers (4.4)
vs Peers
vs Industry
Low liquidity
Beta
-0.1
111% below peers (1.0)
vs Peers
vs Industry
More volatile

TLSA fundamentals radar

TLSA Peer median Industry

TLSA profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

TLSA vs peers: key metrics

Latest News

No related news yet